FDA Drug Label · 2017

OZEMPIC (semaglutide) injection, for subcutaneous use - Prescribing Information

Novo Nordisk (2017). OZEMPIC (semaglutide) injection, for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79

Last reviewed September 19, 2026. By the PeptIQ team.

Peptides linked in PeptIQ Wiki

Semaglutide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.